Individualized ocular characteristics should be considered before starting GLP-1 RA therapies for weight loss and diabetes ...

Migraines are one of the world's most common neurological conditions, impacting nearly 15% of people globally. Despite this ...

GLP-1 drugs like Ozempic® and Zepbound® have gained significant attention for treating both diabetes and assisting with weight loss.

Here’s a roundup of numbers from the last week of HR news — including the percentage of managers who use AI to help determine ...

There was also an 8% lower risk of death from any cause among patients taking GLP-1 drugs like Novo Nordisk's Ozempic (semaglutide) and Eli Lilly's Trulicity (dulaglutide) for diabetes and Novo ...

The UK is studying cases of pancreatitis in people taking GLP-1 drugs for weight loss or type 2 diabetes to see if genetics may make them vulnerable.

Attorney General Dave Sunday is warning Pennsylvanians to make sure they're using licensed pharmacies for GLP-1 drugs amid a growing counterfeit market.

See how GLP-1 drugs reduce heart and kidney complications in MGUS and diabetes—explore the clinical evidence. Keep reading!

A large network meta-analysis ranked eight GLP-1 receptor agonists for glycemic, weight, and safety outcomes in adults with ...

Glucagon-like peptide-1 (GLP-1) receptor agonists significantly enhance overall survival in patients with ovarian cancer, ...

A study published in the Journal of Medical Toxicology by researchers at the University of Alabama at Birmingham found that ...

Investigators examined the comparative effectiveness of SGLT2 inhibitors and GLP-1 receptor agonists in a real-world setting.